Venue: The Fuqua School of Business, Duke University, 1 Towerview Drive, Durham, NC 27708-0120

 

Session

Cost-effectiveness of Preventing and Controlling Diabetes

Chair: Helena Brus (Merck & Co., Inc.)
Organizer: Helena Brus (Merck & Co., Inc.)

Room: RJR Auditorium

When: Tuesday 1 p.m. - 2:30 p.m.

This session will discuss latest research in primary and secondary prevention of diabetes, including use of computer simulation models to prioritize treatments, study the effects of treatments, and guide policy and management of diabetes.

Presentations
TitlePresenterDiscussant
Cost-Effectiveness of Secondary Prevention of Diabetes Complications: A New Evidence-Based Simulation Modeling Approach Jonathan Betz Brown (Kaiser Permanente Center for Health Research)
Larry Radican (Merck & Co. Inc.)
Costs and benefits of primary prevention: Results from the “Diabetes in Europe - Prevention using Lifestyle, physical Activity and Nutritional intervention” (De-PLAN) project in Poland Katarzyna Kissimova-Skarbek (Jagiellonion University in Krakow)
Larry Radican (Merck & Co. Inc.)
Panels Primary Prevention for Type 2 Diabetes Cost-effective? A Systematic Review Rui Li (Centers for Disease Control and Prevention)
Larry Radican (Merck & Co. Inc.)